Prof. Mark Wainberg McGill University, Canada

Mark Wainberg is Director of Research at the Jewish General Hospital as well as Professor of Medicine and Microbiology and Immunology at McGill University, Canada, where he also serves as Director of the McGill University AIDS Centre. Dr. Wainberg is an internationally recognized scientist in the field of HIV/AIDS. He... read moreserved as President of the International AIDS Society between 1998-2000. He is well-known for his initial identification of 3TC as an anti-viral drug, in collaboration with BioChem Pharma Inc, in 1989, as well as for multiple contributions to the field of HIV drug resistance. His laboratory continues to work in the field of drug development, and, as well, Dr. Wainberg has now turned his attention to novel concepts in prevention of HIV infection in developing countries, such as vaginal microbicides and pre-exposure prophylaxis.